Seer, Inc. financial data

Symbol
SEER on Nasdaq
Industry
Laboratory Analytical Instruments
Location
3800 Bridge Parkway, Suite 102, Redwood City, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
Seer Biosciences, Inc. (to 1/4/2018)
Latest financial report
10-Q - Q3 2024 - Nov 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.12K % -24.8%
Quick Ratio 43.2 % +27.5%
Debt-to-equity 10.6 % +11.1%
Return On Equity -22.2 % -3.89%
Return On Assets -20.1 % -2.87%
Operating Margin -677 % -7.24%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 64M shares +2.14%
Entity Public Float 232M USD -45.5%
Weighted Average Number of Shares Outstanding, Basic 61.2M shares -4.29%
Weighted Average Number of Shares Outstanding, Diluted 61.2M shares -4.29%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 14.6M USD -13.2%
Cost of Revenue 7.58M USD -5.62%
Research and Development Expense 49.1M USD -9.83%
General and Administrative Expense 14.8M USD -4.39%
Operating Income (Loss) -98.8M USD +6.91%
Nonoperating Income (Expense) 16.2M USD +6.67%
Net Income (Loss) Attributable to Parent -82.7M USD +9.17%
Earnings Per Share, Basic -1.29 USD/shares +10.4%
Earnings Per Share, Diluted -1.29 USD/shares +10.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 37.6M USD +3.37%
Cash, Cash Equivalents, and Short-term Investments 248M USD -25.2%
Accounts Receivable, after Allowance for Credit Loss, Current 4.83M USD +12%
Inventory, Net 6.94M USD +64.1%
Assets, Current 264M USD -23.7%
Property, Plant and Equipment, Net 20.7M USD -4.85%
Operating Lease, Right-of-Use Asset 23.3M USD -9.42%
Other Assets, Noncurrent 9.88M USD +775%
Assets 383M USD -13.8%
Accrued Liabilities, Current 10.9M USD +19.2%
Contract with Customer, Liability, Current 354K USD +91.4%
Liabilities, Current 14.4M USD +14.9%
Operating Lease, Liability, Noncurrent 24.3M USD -8.49%
Other Liabilities, Noncurrent 64K USD -59.2%
Liabilities 38.7M USD -1.22%
Accumulated Other Comprehensive Income (Loss), Net of Tax 789K USD
Retained Earnings (Accumulated Deficit) -371M USD -28.7%
Stockholders' Equity Attributable to Parent 345M USD -15%
Liabilities and Equity 383M USD -13.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -10.5M USD +45.9%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities 32.4M USD +123%
Common Stock, Shares Authorized 105M shares 0%
Common Stock, Shares, Issued 64M shares +2.14%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 21.9M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 38.1M USD +3.32%
Deferred Tax Assets, Valuation Allowance 74M USD +34.6%
Deferred Tax Assets, Gross 81M USD +30.3%
Operating Lease, Liability 26.5M USD -8.02%
Depreciation 6.3M USD +26%
Payments to Acquire Property, Plant, and Equipment 754K USD +523%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -80.6M USD +10.1%
Lessee, Operating Lease, Liability, to be Paid 33.9M USD -10.6%
Property, Plant and Equipment, Gross 37.4M USD +14.2%
Operating Lease, Liability, Current 2.25M USD -2.64%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.96M USD +2.89%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.85M USD -3.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7.38M USD -18.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.07M USD +2.91%
Deferred Tax Assets, Operating Loss Carryforwards 41.2M USD +24.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 2.36M USD +49.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.19M USD +2.92%
Operating Lease, Payments 1.01M USD +2.65%
Additional Paid in Capital 715M USD +2.82%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 7.14M USD +22.5%
Share-based Payment Arrangement, Expense 29.4M USD -16%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%